Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells

Zongchao Han, Li Zhong, Njeri Maina, Zhongbo Hu, Xiaomiao Li, Nitin S. Chouthai, Daniela Bischof, Kirsten A. Weigel-Van Aken, William B. Slayton, Mervin Yoder, Arun Srivasta

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We previously reported that among single-stranded adeno-associated virus (ssAAV) vectors, serotypes 1 through 5, ssAAV1 is the most efficient in transducing murine hematopoietic stem cells (HSCs), but viral second-strand DNA synthesis remains a rate-limiting step. Subsequently, using double-stranded, self-complementary AAV (scAAV) vectors, serotypes 7 through 10, we observed that scAAV7 vectors also transduce murine HSCs efficiently. In the present study, we used scAAV1 and scAAV7 shuttle vectors to transduce HSCs in a murine bone marrow serial transplant model in vivo, which allowed examination of the AAV proviral integration pattern in the mouse genome, as well as recovery and nucleotide sequence analyses of AAV-HSC DNA junction fragments. The proviral genomes were stably integrated, and integration sites were localized to different mouse chromosomes. None of the integration sites was found to be in a transcribed gene, or near a cellular oncogene. None of the animals, monitored for up to 1 year, exhibited pathological abnormalities. Thus, AAV proviral integration-induced risk of oncogenesis was not found in our study, which provides functional confirmation of stable transduction of self-renewing multipotential HSCs by scAAV vectors as well as promise for the use of these vectors in the potential treatment of disorders of the hematopoietic system.

Original languageEnglish
Pages (from-to)267-278
Number of pages12
JournalHuman Gene Therapy
Volume19
Issue number3
DOIs
StatePublished - Mar 1 2008

Fingerprint

Dependovirus
Hematopoietic Stem Cells
Genome
Hematopoietic System
Genetic Vectors
Intercellular Junctions
DNA
Oncogenes
Sequence Analysis
Carcinogenesis
Chromosomes
Bone Marrow
Transplants
Genes

ASJC Scopus subject areas

  • Genetics

Cite this

Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells. / Han, Zongchao; Zhong, Li; Maina, Njeri; Hu, Zhongbo; Li, Xiaomiao; Chouthai, Nitin S.; Bischof, Daniela; Weigel-Van Aken, Kirsten A.; Slayton, William B.; Yoder, Mervin; Srivasta, Arun.

In: Human Gene Therapy, Vol. 19, No. 3, 01.03.2008, p. 267-278.

Research output: Contribution to journalArticle

Han, Z, Zhong, L, Maina, N, Hu, Z, Li, X, Chouthai, NS, Bischof, D, Weigel-Van Aken, KA, Slayton, WB, Yoder, M & Srivasta, A 2008, 'Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells', Human Gene Therapy, vol. 19, no. 3, pp. 267-278. https://doi.org/10.1089/hum.2007.161
Han, Zongchao ; Zhong, Li ; Maina, Njeri ; Hu, Zhongbo ; Li, Xiaomiao ; Chouthai, Nitin S. ; Bischof, Daniela ; Weigel-Van Aken, Kirsten A. ; Slayton, William B. ; Yoder, Mervin ; Srivasta, Arun. / Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells. In: Human Gene Therapy. 2008 ; Vol. 19, No. 3. pp. 267-278.
@article{81f3acef3e924ab883816e8146879dbe,
title = "Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells",
abstract = "We previously reported that among single-stranded adeno-associated virus (ssAAV) vectors, serotypes 1 through 5, ssAAV1 is the most efficient in transducing murine hematopoietic stem cells (HSCs), but viral second-strand DNA synthesis remains a rate-limiting step. Subsequently, using double-stranded, self-complementary AAV (scAAV) vectors, serotypes 7 through 10, we observed that scAAV7 vectors also transduce murine HSCs efficiently. In the present study, we used scAAV1 and scAAV7 shuttle vectors to transduce HSCs in a murine bone marrow serial transplant model in vivo, which allowed examination of the AAV proviral integration pattern in the mouse genome, as well as recovery and nucleotide sequence analyses of AAV-HSC DNA junction fragments. The proviral genomes were stably integrated, and integration sites were localized to different mouse chromosomes. None of the integration sites was found to be in a transcribed gene, or near a cellular oncogene. None of the animals, monitored for up to 1 year, exhibited pathological abnormalities. Thus, AAV proviral integration-induced risk of oncogenesis was not found in our study, which provides functional confirmation of stable transduction of self-renewing multipotential HSCs by scAAV vectors as well as promise for the use of these vectors in the potential treatment of disorders of the hematopoietic system.",
author = "Zongchao Han and Li Zhong and Njeri Maina and Zhongbo Hu and Xiaomiao Li and Chouthai, {Nitin S.} and Daniela Bischof and {Weigel-Van Aken}, {Kirsten A.} and Slayton, {William B.} and Mervin Yoder and Arun Srivasta",
year = "2008",
month = "3",
day = "1",
doi = "10.1089/hum.2007.161",
language = "English",
volume = "19",
pages = "267--278",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells

AU - Han, Zongchao

AU - Zhong, Li

AU - Maina, Njeri

AU - Hu, Zhongbo

AU - Li, Xiaomiao

AU - Chouthai, Nitin S.

AU - Bischof, Daniela

AU - Weigel-Van Aken, Kirsten A.

AU - Slayton, William B.

AU - Yoder, Mervin

AU - Srivasta, Arun

PY - 2008/3/1

Y1 - 2008/3/1

N2 - We previously reported that among single-stranded adeno-associated virus (ssAAV) vectors, serotypes 1 through 5, ssAAV1 is the most efficient in transducing murine hematopoietic stem cells (HSCs), but viral second-strand DNA synthesis remains a rate-limiting step. Subsequently, using double-stranded, self-complementary AAV (scAAV) vectors, serotypes 7 through 10, we observed that scAAV7 vectors also transduce murine HSCs efficiently. In the present study, we used scAAV1 and scAAV7 shuttle vectors to transduce HSCs in a murine bone marrow serial transplant model in vivo, which allowed examination of the AAV proviral integration pattern in the mouse genome, as well as recovery and nucleotide sequence analyses of AAV-HSC DNA junction fragments. The proviral genomes were stably integrated, and integration sites were localized to different mouse chromosomes. None of the integration sites was found to be in a transcribed gene, or near a cellular oncogene. None of the animals, monitored for up to 1 year, exhibited pathological abnormalities. Thus, AAV proviral integration-induced risk of oncogenesis was not found in our study, which provides functional confirmation of stable transduction of self-renewing multipotential HSCs by scAAV vectors as well as promise for the use of these vectors in the potential treatment of disorders of the hematopoietic system.

AB - We previously reported that among single-stranded adeno-associated virus (ssAAV) vectors, serotypes 1 through 5, ssAAV1 is the most efficient in transducing murine hematopoietic stem cells (HSCs), but viral second-strand DNA synthesis remains a rate-limiting step. Subsequently, using double-stranded, self-complementary AAV (scAAV) vectors, serotypes 7 through 10, we observed that scAAV7 vectors also transduce murine HSCs efficiently. In the present study, we used scAAV1 and scAAV7 shuttle vectors to transduce HSCs in a murine bone marrow serial transplant model in vivo, which allowed examination of the AAV proviral integration pattern in the mouse genome, as well as recovery and nucleotide sequence analyses of AAV-HSC DNA junction fragments. The proviral genomes were stably integrated, and integration sites were localized to different mouse chromosomes. None of the integration sites was found to be in a transcribed gene, or near a cellular oncogene. None of the animals, monitored for up to 1 year, exhibited pathological abnormalities. Thus, AAV proviral integration-induced risk of oncogenesis was not found in our study, which provides functional confirmation of stable transduction of self-renewing multipotential HSCs by scAAV vectors as well as promise for the use of these vectors in the potential treatment of disorders of the hematopoietic system.

UR - http://www.scopus.com/inward/record.url?scp=41149140461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149140461&partnerID=8YFLogxK

U2 - 10.1089/hum.2007.161

DO - 10.1089/hum.2007.161

M3 - Article

C2 - 18303957

AN - SCOPUS:41149140461

VL - 19

SP - 267

EP - 278

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 3

ER -